TH-302 Articles
US and European oncologists see novel chemotherapies as best hope for soft tissue sarcoma
30 January 2013
Merck Serono initiation of TH-302 Ph III trial triggers $30 million milestone for Threshold
29 January 2013
News briefs from Threshold, Merck KGaA and GSK
18 September 2012
Showing 1-3 of 3 articles
- 1
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
